(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PHARMASEAL

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PHARMASEAL

ST13

US500000088274762

Classe

9, 41, 42, 45

Pedido

88274762

Registro

6104779

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

22/07/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 41, 42, 45

Data de depósito

24/01/2019

Data de registro

21/07/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/07/2020

Última transação

22/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Nottingham, GB

Examinador

MIRANDA, JOHN

Unidade examinadora

N20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

PharmaSEAL International Limited

Representantes

Molly B. Markley YOUNG, BASILE, HANLON & MACFARLANE P.C.

Classificação técnica

Classes Nice

Classe 9Classe 41Classe 42Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Downloadable computer software for management of clinical trials; downloadable computer software for clinical and scientific research purposes; downloadable platform software for management of clinical trials; downloadable platform software for clinical and scientific research purposes; downloadable software applications in the nature of computer software for management of clinical trials; downloadable software applications for clinical and scientific research purposes; downloadable software for management of clinical trials; downloadable software for clinical and scientific research purposes; downloadable computer software for purposes related to clinical research and clinical trials; downloadable computer software for use in clinical research and clinical trials; downloadable computer software for use in the collection and management of clinical data; downloadable computer software for the collectionentryanalysismanagement and validation of clinical research and clinical trial data; downloadable computer software for managing clinical trial data and information; downloadable computer software for use in the remote or local collection of clinical trial data; downloadable computer software for use in clinical trial design and development; downloadable computer software for use in clinical trial planning and management; downloadable computer software for use in clinical trial patient randomisation; downloadable computer software for use in clinical trial patient monitoring; downloadable computer software for use in clinical trial data management and analysis; electronic databases in the field of clinical and scientific researchrecorded on computer media; electronic databases in the field of clinical trialsrecorded on computer media; database management software; downloadable audio materialsaudio-visual materials and video materialsdownloadable audio and video files relating to the pharmaceutical industriesdrug developmentclinical researchscientific researchclinical testclinical trials and regulatory affairs; downloadable electronic publications in the nature of magazines about the pharmaceuticals industrydrug developmentclinical researchscientific researchclinical testclinical trials and regulatory affairs

Classe 41

Educational services and trainingproviding classes in the field of the pharmaceutical industriesdrug developmentclinical researchscientific researchclinical testclinical trials and regulatory affairs; educational servicesclasses in the field of the pharmaceutical industries; educational consulting services for pharmaceutical industries; training services for the pharmaceutical industries; educational servicesproviding classestraining services and workshops in the field of the pharmaceutical industriesdrug developmentclinical researchscientific researchclinical testclinical trials and regulatory affairs; educational servicesproviding classestraining services and workshops in relation to pharmaceutical industries; educational servicesarranging and conducting workshops in the field of the pharmaceutical industries; educational servicesworkshops for training purposes in the field of the pharmaceutical industries drug developmentclinical researchscientific researchclinical testclinical trials and regulatory affairs

Classe 42

Software as a services (SaaS) featuring software for management of clinical trials; software as a services (SaaS) featuring software for clinical research and clinical trials; software as a services (SaaS) featuring software for management of clinical test and trials; software as a services (SaaS) featuring software for clinical testing; providing online non-downloadable software for clinical research and clinical trials; providing online non-downloadable software for clinical research and clinical trials; providing online non-downloadable software for management of clinical trials; providing online non-downloadable software for clinical testing; software customisation services; customisation of software for clinical research or clinical trials; customisation of software for management of clinical trials; customisation of software for clinical testing; design and development of computer softwarecomputer programs and computer systems; design and development of computer softwarecomputer programs and computer systems for clinical research and clinical trials; informationadvisory and consultancy services in relation to the aforesaid services

Classe 45

Consulting services in relation to regulatory compliance in the pharmaceutical industries; consulting services for the pharmaceutical industry in relation to the regulatory compliance of software; advisory and consultancy servicesregulatory compliance consulting services in the field of regulatory affairs and drug development; advisory and information services relating to all the aforesaid services

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

21/07/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

21/07/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/05/2020

PUBO

PUBLISHED FOR OPPOSITION

05/05/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

15/04/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/04/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/03/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

19/03/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/10/2019

GNSL

LETTER OF SUSPENSION E-MAILED

07/10/2019

CNSL

SUSPENSION LETTER WRITTEN

07/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/09/2019

ALIE

ASSIGNED TO LIE

16/09/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/09/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

13/03/2019

GNRT

NON-FINAL ACTION E-MAILED

13/03/2019

CNRT

NON-FINAL ACTION WRITTEN

13/03/2019

DOCK

ASSIGNED TO EXAMINER

07/03/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/02/2019

NWAP

NEW APPLICATION ENTERED

28/01/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PHARMASEAL ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.